image

As a high-tech biotechnology company, Lansion Biotechnology Co., Ltd.( Lansionbio) is specialized in research & development, production, sales and services of in vitro diagnostic reagents and devices. And its members of core R&D team all come from well-known research institutions and bio-pharmaceutical companies. With its advanced technologies, Lansionbio provides equipment, reagents and services to world-wide clients to meet their needs.

With its international leading technology, Lansionbio has obtained ISO13485 certificate and built a R&D center covering 20,000 square meters, which also has a more than 4,000 square meters aseptic purification cleanroom meeting GMP standard. Presently Lansionbio has 4 subsidiaries in Guangxi, Shanxi, Chengdu and Nanjing, providing products including IVD devices and reagents.

Lansionbio has been always upholding the innovation, committing to breakthrough, insisting on the R&D work from beginning. Now Lansionbio has already built up 3 world-leading platforms: microfluidics, immunochromatography, molecular diagnosis. Lansionbio has won great trusts from numerous customers by its world-leading quality standards.

Lansionbio takes “Strive for excellence, care every life and health” as purpose, focuses on innovation and quality and devotes to improve the human health by providing high-quality, reliable and affordable POCT produts and services.

Company’s Keywords:

medical equipment, blood analyzer, biotechnology, fluorescence immunity analyzer, quantitative immunoassay analyzer, diagnostic reagent, poct, ivd, test kits

Q How Many Employees Does This Company Have?

62

Q Which Industry Does This Company Belong To?

medical devices

Q What Is the Annual Income?

8000000

Q What Is the Technology of All the Company’s Website?

Microsoft Office 365, Apache, Mobile Friendly

Q What Year Was the Company Founded?

2016

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image